Centre For Probe Development And Commercialization Products Recall (2019-04-17)
Recall Summary Centre for Probe Development and Commercialization has recalled certain drug products distributed across Canada due to safety concerns. The affected products were classified as a Class I recall, meaning there is a serious risk of adverse health effects. The recall applies to all Canadian consumers who may have purchased these products.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2019-04-17
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/6bc9d105-7448-4b72-8a7c-890c28a89ae3